| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Depts of 1 Respiratory and Sleep Medicine and 2 Paediatric Endocrinology, Monash Medical Centre and 3 Centre for Heart and Chest Research, Monash University, Melbourne, Australia
CORRESPONDENCE: N. Freezer, Respiratory and Sleep Medicine, Monash Medical Centre, Melbourne, Australia. Fax: 61 395946415. E-mail: n.freezer@southernhealth.org.au
Keywords: adrenal suppression, asthma, children, flixotide
Received: January 3, 2002
Accepted May 25, 2002
This cross-sectional study was designed to examine the prevalence of adrenocortical suppression in children with asthma treated with high-dose inhaled fluticasone propionate (FP).
Children and adolescents (n=50) with asthma, treated with inhaled FP at a dose of
Fifty subjects of mean age 13.1 yrs were treated with a mean dose of 924.7 µg·m–2·day–1 FP for a mean duration of 2 yrs. Of the 50 subjects, 36 (72%) had serum cortisol levels of <400 nmol·L–1 and underwent tetracosactrin stimulation test. Of these, 6 (17%) demonstrated a less than two-fold increase in serum cortisol from baseline and peak cortisol level of
Biochemical evidence of adrenocortical insufficiency was demonstrated in 12% of the subjects, indicating that high-dose fluticasone propionate use may be associated with dose-dependent adrenocortical suppression.
1,000 mg a day for 6 months, were enrolled. Early morning serum cortisol was performed. Subjects with a serum cortisol of <400 nmol·L–1 had a tetracosactrin stimulation test. 
550 nmol·L–1 at 30 or 60 min poststimulation. There was a significant negative correlation between the dose of FP·m–2 and stimulated peak cortisol level.
This article has been cited by other articles:
|
|
 |
|
  J Paton, E Jardine, E McNeill, S Beaton, P Galloway, D Young, and M Donaldson Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone Arch. Dis. Child., October 1, 2006; 91(10): 808 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D R Woods, C S Arun, P A Corris, and P Perros Cushing's syndrome without excess cortisol. BMJ, February 25, 2006; 332(7539): 469 - 470. [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Priftis, A. Papadimitriou, E. Gatsopoulou, P. K. Yiallouros, A. Fretzayas, and P. Nicolaidou The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children Eur. Respir. J., February 1, 2006; 27(2): 316 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Saglani, A. G. Nicholson, M. Scallan, I. Balfour-Lynn, M. Rosenthal, D. N. Payne, and A. Bush Investigation of young children with severe recurrent wheeze: any clinical benefit? Eur. Respir. J., January 1, 2006; 27(1): 29 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Tattersfield, T. W. Harrison, R. B. Hubbard, and K. Mortimer Safety of Inhaled Corticosteroids Proceedings of the ATS, November 1, 2004; 1(3): 171 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Mahachoklertwattana, K Sudkronrayudh, C Direkwattanachai, L Choubtum, and C Okascharoen Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate Arch. Dis. Child., November 1, 2004; 89(11): 1055 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.J. Visser, E. van der Veer, D.S. Postma, L.R. Arends, T.W. de Vries, P.L.P. Brand, and E.J. Duiverman Side-effects of fluticasone in asthmatic children: no effects after dose reduction Eur. Respir. J., September 1, 2004; 24(3): 420 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mohn, M. Verini, R. Mele, C. De Leonardis, and F. Chiarelli Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma Eur. Respir. J., February 1, 2004; 23(2): 354 - 355. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
